Returns & Covenant — GEISINGER WYOMING VALLEY MED CTR
IRR: 16.1% | MOIC: 2.11x | Covenant cushion: 21%
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
16.1%
IRR
2.11x
MOIC
$210M
Entry Equity
$443M
Exit Proceeds
$443M
Total Distributions
5.0yr
Hold Period
Returns Assessment
Marginal — in the 15-20% range, needs operational upside. At 16.1% IRR and 2.11x MOIC over 5 years, every $1 invested returns $2.11.
Entry equity of $210M grows to $443M in total distributions — a $233M gain.
Covenant Headroom
How much EBITDA can compress before the leverage covenant trips?
5.5x
Actual Leverage
7.0x
Covenant Max
1.5x
Headroom (turns)
21%
EBITDA Cushion
$37M
Covenant Trips at
2.8x
Interest Coverage
Plain English: EBITDA can decline 21% (from $47M to $37M) before the 7.0x leverage covenant trips. This is tight — stress test carefully.